OTC Markets EXMKT - Delayed Quote USD
Eagle Pharmaceuticals, Inc. (EGRX)
1.7000
-0.2700
(-13.71%)
At close: April 25 at 2:56:53 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-9,318
50,701
28,219
49,497
Investing Cash Flow
-23,810
-86,830
-5,323
-18,247
Financing Cash Flow
11,920
-6,209
-28,392
-37,870
End Cash Position
15,354
55,321
97,659
103,155
Income Tax Paid Supplemental Data
37,197
28,410
10,005
6,428
Interest Paid Supplemental Data
4,060
1,726
1,197
2,224
Capital Expenditure
-74
-178
-323
-747
Issuance of Debt
110,000
80,000
--
110,000
Repayment of Debt
-85,736
-67,236
-8,000
-115,000
Repurchase of Capital Stock
-9,951
-18,004
-21,213
-34,999
Free Cash Flow
-9,392
50,523
27,896
48,750
12/31/2020 - 2/12/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
COLL Collegium Pharmaceutical, Inc.
26.79
+0.04%
ANIP ANI Pharmaceuticals, Inc.
69.82
+0.26%
INNPF InnoCan Pharma Corporation
0.1400
0.00%
MRKC.F Merck KGaA
23.60
0.00%
MKGAF Merck KGaA
138.65
+1.02%
ALKS Alkermes plc
27.84
+0.61%
PCRX Pacira BioSciences, Inc.
25.72
-1.08%
CPIX Cumberland Pharmaceuticals Inc.
4.9700
+2.58%
EBS Emergent BioSolutions Inc.
5.49
+2.23%
PRFX PainReform Ltd.
2.3500
+1.29%